patentstorm.us 258 85 http://www.patentstorm.us/ http://www.patentstorm.us/images/logo.gif PatentStorm -> Applications -> Organic compounds -- part of the class 532-570 series http://www.patentstorm.us/rss/class/applications/rss-564.xml Recent patent applications filings in USPTO Class 564 Organic compounds -- part of the class 532-570 series. Thu, 9 Feb 2012 15:01:47 patents@patentstorm.us en <![CDATA[PROCESS FOR PREPARING MDA VIA THE STAGE OF THE AMINAL]]> http://www.patentstorm.us/applications/20120035396/description.html
  • Application Number:  20120035396
  • Publication Date:  2012-02-09
  • Inventors:  Zoellinger, Michael; Stroefer, Eckhard; Thiele, Kai; Moors, Johnny; Speier, Jon S.
    • The invention relates to a process for preparing methylenediphenyldiamine (MDA), comprising the following steps a) to c):
      • a) converting formaldehyde and aniline to aminal
      • b) removing water from the aminal obtained in step a) to establish a water content of 0 to 5% by weight based on the aminal, ...
        ]]> 20120035396 <![CDATA[POLYHYDROXY-DIAMINES AS MULTI-FUNCTIONAL ADDITIVES FOR PAINTS, COATINGS AND EPOXIES]]> http://www.patentstorm.us/applications/20120035298/description.html
      • Application Number:  20120035298
      • Publication Date:  2012-02-09
      • Inventors:  Tomlinson, Ian A.; Peera, Asghar A.
      Provided are polyhydroxy-diamine compounds of the formula I: or salt thereof, wherein R1, R2, and R3 are as defined herein. The compounds are useful as low additives for paints, coatings and epoxy formulations.

      ]]> 20120035298 <![CDATA[CYCLOPROPENE AMINE COMPOUNDS]]> http://www.patentstorm.us/applications/20120035269/description.html

    • Application Number:  20120035269
    • Publication Date:  2012-02-09
    • Inventor:  Sisler, Edward C.
    Methods of applying cyclopropene amine derivatives and compositions thereof to inhibit ethylene receptors in plants and plant material are disclosed. Methods include applying to the plant an effective ethylene response-inhibiting amount of at least one cyclopropene amine compound or composition thereof. Cyclopropene amine compounds, enantiomers, stereoisomers or salts thereof are also ...
    ]]>     20120035269     <![CDATA[SPHINGO-GUANIDINES AND THEIR USE AS INHIBITORS OF SPHINGOSINE KINASE]]> http://www.patentstorm.us/applications/20120035268/description.html
  • Application Number:  20120035268
  • Publication Date:  2012-02-09
  • Inventors:  Norris, James; Bielawska, Alicja; Xiang, Liu; Szulc, Zdzislaw M.; Hannun, Yusuf A.; Obeld, Lina M.
    • The presently disclosed subject matter provides compounds of the formula: (1) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, and R8 are as defined herein. Also disclosed are methods for making the compounds of the formula as set forth hereinabove, their use in inhibiting sphingosine kinase, and their use in the treatment and/or prevention of diseases and/or conditions ...
    ]]>     20120035268     <![CDATA[BILE ACIDS AND BIGUANIDES AS PROTEASE INHIBITORS FOR PRESERVING THE INTEGRITY OF PEPTIDES IN THE GUT]]> http://www.patentstorm.us/applications/20120035116/description.html
  • Application Number:  20120035116
  • Publication Date:  2012-02-09
  • Inventors:  New, Roger R., C.; Travers, Glen
    • This invention relates to methods of preserving the integrity of peptides in the gut. In particular it concerns the use of certain compounds as inhibitors of gut proteases. Compounds identified as having gut protease inhibitory activity are biguanides, certain bile acids and pharmaceutically acceptable salts of these compounds. This activity makes these compounds useful for co-administration with prophylactic or therapeutic peptides. This invention relates to methods of inhibiting gut proteases ...
    ]]>     20120035116     <![CDATA[DIAMOND PARTICLES HAVING ORGANIC COMPOUNDS ATTACHED THERETO, COMPOSITIONS THEREOF, AND RELATED METHODS]]> http://www.patentstorm.us/applications/20120034464/description.html
  • Application Number:  20120034464
  • Publication Date:  2012-02-09
  • Inventors:  Agrawal, Gaurav; DiGiovanni, Anthony A.; Chakraborty, Soma
    • A substance includes diamond particles having a maximum linear dimension of less than about 1 μm and an organic compound attached to surfaces of the diamond particles. The organic compound may include a surfactant or a polymer. A method of forming a substance includes exposing diamond particles to an organic compound, and exposing the diamond particles in the presence of the organic compound to ultrasonic energy. The diamond particles may have a maximum linear dimension of less than about 1 ...
    ]]>     20120034464     <![CDATA[S1P Receptors Modulators]]> http://www.patentstorm.us/applications/20120034270/description.html
  • Application Number:  20120034270
  • Publication Date:  2012-02-09
  • Inventors:  Grobelny, Damian W.; Gill, Gurmit S.
    • The invention relates to novel compounds that have S1P receptor modulating activity and, preferably, apoptotic activity and/or anti proliferative activity against cancer cells and other cell types. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with in-appropriate S1P receptor modulating activity or expression, for example, cancer. A further aspect of the invention ...
    ]]>     20120034270     <![CDATA[Asymmetrical Aryl Amine Derivative for Organic Electroluminescence Devices, Method for Preparing Same, Organic Thin Film for Organic Electroluminescence Devices and Organic Electroluminescence Device Using Same]]> http://www.patentstorm.us/applications/20120032152/description.html
  • Application Number:  20120032152
  • Publication Date:  2012-02-09
  • Inventors:  Oh, Yong Ho; Kim, Sang Dong; Kim, Se Hun; Lee, Ji Hye
    • Provided are asymmetric arylamine derivatives for an organic electroluminescent element, represented by the formula (1), which is prepared by sequentially inducing a secondary amine and a tertiary amine to an aryl compound Ar core so that they do not include a symmetrical axis and a symmetrical surface in a molecule, a manufacturing method of the same, an organic thin layer material including the asymmetric arylamine derivatives, and an organic electroluminescent element employing the ...
    ]]>     20120032152     <![CDATA[PREPARATION OF MONOBASIC PHOSPHATE IONOPHORES]]> http://www.patentstorm.us/applications/20120031775/description.html
  • Application Number:  20120031775
  • Publication Date:  2012-02-09
  • Inventor:  Ahmad, Mohd Rais
    • The present invention relates to the synthesis of lipophilic or immobilized monobasic phosphate (H2PO4) ionophores (7, 8a, 8b and 11) to be used as ion recognition molecules for monobasic phosphate (H2PO4″) in the cocktail preparation of hydrophobic polymer membranes in ion selective electrode (ISE) or ion-sensitive field effect transistor (ISFET) chemical sensors for detection of monobasic phosphate (H2PO4) ionic species in soil, ...
    ]]>     20120031775     <![CDATA[METHOD FOR STORING TRANSDERMALLY/TRANSMUCOSALLY ABSORBABLE PREPARATION AND PACKAGE OF TRANSDERMALLY/TRANSMUCOSALLY ABSORBABLE PREPARATION]]> http://www.patentstorm.us/applications/20120031047/description.html
  • Application Number:  20120031047
  • Publication Date:  2012-02-09
  • Inventors:  SHINODA, Tomohiro; Yasukouchi, Takashi; Takada, Yasunori
    • A method for storing a transdermally/transmucosally absorbable preparation, comprising keeping a transdermally/transmucosally absorbable preparation enclosed in a container in a low oxygen atmosphere, the transdermally/transmucosally absorbable preparation comprising a drug whose molecule has an amino group substituted with a lower alkyl ...
    ]]>     20120031047     <![CDATA[Autocatalytic Process for the Synthesis of Chiral Propargylic Alcohols]]> http://www.patentstorm.us/applications/20120029237/description.html
  • Application Number:  20120029237
  • Publication Date:  2012-02-02
  • Inventors:  Carreira, Erick; Chinkov, Nicka; Warm, Aleksander
    • An autocatalytic process for the synthesis of chiral propargylic ...
    ]]>     20120029237     <![CDATA[CAPPED STRUCTURE ORGANIC FILM COMPOSITIONS]]> http://www.patentstorm.us/applications/20120029236/description.html
  • Application Number:  20120029236
  • Publication Date:  2012-02-02
  • Inventors:  Heuft, Matthew A.; Cöté, Adrien P.
    • A capped structured organic film comprising a plurality of segments and a plurality of linkers arranged as a covalent organic framework, wherein the structured organic film may be a multi-segment thick structured organic ...
    ]]>     20120029236     <![CDATA[COMPOUNDS FOR USE IN THE TREATMENT OF PAIN]]> http://www.patentstorm.us/applications/20120029235/description.html
  • Application Number:  20120029235
  • Publication Date:  2012-02-02
  • Inventors:  Leuwer, Martin; O'Neill, Paul; Berry, Neil; Haeseler, Gertrud
    • The present invention concerns compounds derived from the anaethetic propofol. The compounds may be useful in the treatment of pain, particularly, but not exclusively, chronic pain and central pain ...
    ]]>     20120029235     <![CDATA[BORON CONTAINING FUNCTIONALIZING AGENT]]> http://www.patentstorm.us/applications/20120029234/description.html
  • Application Number:  20120029234
  • Publication Date:  2012-02-02
  • Inventors:  Rodewald, Stephan; Woloszynek, Robert Alan
    • The present invention relates to functionalizing agents that are particularly useful for functionalizing living rubbery polymers to make the polymer more compatible with fillers, such as carbon black and silica. These functionalizing agents are comprised of a boron containing compound having a structural formula selected from the group consisting of:

    wherein R is selected from the group consisting of hydrogen atoms, alkyl groups and ...
    ]]> 20120029234 <![CDATA[METHOD AND APPARATUS FOR RECOVERY OF AMINE FROM AMINE-CONTAINING WASTE WATER AND REGENERATION OF CATION EXCHANGE RESIN]]> http://www.patentstorm.us/applications/20120029233/description.html

  • Application Number:  20120029233
  • Publication Date:  2012-02-02
  • Inventors:  RHEE, In-Hyoung; JUNG, Hyun-Jun
    • Provided is an apparatus for recovering amines from amine-containing waste water generated in power stations, etc., and regenerating a cation exchange resin. The apparatus includes: a cation exchange resin layer capturing amines from amine-containing waste water and eluting the amines therefrom; a degassing tower degassing the eluted amines; a vacuum pump connected to the degassing tower; and a condensation and cooling tower condensing the degassed amines at a temperature of −33° C. or ...
    ]]>     20120029233     <![CDATA[DMAPN Having a Low DGN Content and a Process for Preparing DMAPA from DMAPN Having a Low DGN Content]]> http://www.patentstorm.us/applications/20120029225/description.html
  • Application Number:  20120029225
  • Publication Date:  2012-02-02
  • Inventors:  Mägerlein, Wolfgang; Köhler, Ulrich; Eberhardt, Jan; Melder, Johann-Peter; Hahn, Thilo; Kreitschmann, Mirko; Herbrecht, Dominik
    • The present invention relates to a process for preparing 3-dimethylaminopropylamine (DMAPA) by reacting 3-dimethylaminopropionitrile (DMAPN) with hydrogen in the presence of a catalyst, wherein the DMAPN used has a content of 2-(dimethylaminomethyl)glutaronitrile (DGN) of 300 ppm by weight or less, based on the DMAPN used.

    Furthermore, the present invention relates to mixtures of DMAPN and DGN, wherein the weight ratio of DMAPN to DGN is in the range from 1 000 ...
    ]]> 20120029225 <![CDATA[Synthesis Of Triethylenetetramines]]> http://www.patentstorm.us/applications/20120029203/description.html

  • Application Number:  20120029203
  • Publication Date:  2012-02-02
  • Inventors:  Jonas, Marco; Vaulont, Irene; Soi, Antonio; Schmidt, Gunther
    • Methods and intermediates for synthesizing triethylenetetramine and salts thereof, as well as novel triethylenetetramine salts and their crystal structure, and triethylenetetramine salts of high ...
    ]]>     20120029203     <![CDATA[Pyrazole Derivatives]]> http://www.patentstorm.us/applications/20120029192/description.html
  • Application Number:  20120029192
  • Publication Date:  2012-02-02
  • Inventors:  Jones, Lyn Howard; Price, David Anthony; Selby, Matthew Duncan; Mowbray, Charles Eric; Stupple, Paul Anthony
    • This invention relates to pyrazole derivatives of formula (I)

    or pharmaceutically acceptable salts, solvates or derivatives thereof, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such, the ...
    ]]> 20120029192 <![CDATA[Substituted Aniline Derivatives]]> http://www.patentstorm.us/applications/20120029188/description.html

  • Application Number:  20120029188
  • Publication Date:  2012-02-02
  • Inventors:  Carr, Andrew David; Neuss, Judi Charlotte; Orchard, Michael Glen; Porter, David William
    • The present invention relates to novel aniline derivatives and their use in therapy, in particular their use in the treatment of fungal ...
    ]]>     20120029188     <![CDATA[AUTO MAGNETIC METAL SALEN COMPLEX COMPOUND]]> http://www.patentstorm.us/applications/20120029167/description.html
  • Application Number:  20120029167
  • Publication Date:  2012-02-02
  • Inventors:  Eguchi, Haruki; ISHIKAWA, Yoshihiro
    • A drug using the magnetic properties of a metal salen complex as represented by the following general formula in order to magnetize the intended drug by chemically binding the drug to a metal salen complex so that the drug can be delivered to the target diseased site. The drug can be delivered to the diseased site using the magnetic properties of the drug per se without using a carrier made of a magnetic substance as in the conventional methods.

    ]]> 20120029167 <![CDATA[POLYMORPHIC FORMS OF ALISKIREN HEMIFUMARATE AND PROCESS FOR PREPARATION THEREOF]]> http://www.patentstorm.us/applications/20120029083/description.html

  • Application Number:  20120029083
  • Publication Date:  2012-02-02
  • Inventors:  Finkelstein, Nina; Mittelman, Ariel; Koltai, Tamás; Finkelstein, Boris
    • Provided are amorphous and polymorphic forms of aliskiren hemifumarate, pharmaceutical compositions thereof, and processes for their ...
    ]]>     20120029083     <![CDATA[Polyphenol Proteasome Inhibitors, Synthesis, and Methods of Use]]> http://www.patentstorm.us/applications/20120029067/description.html
  • Application Number:  20120029067
  • Publication Date:  2012-02-02
  • Inventors:  DOU, Q. Ping; CHAN, Tak-Hang; SMITH, David M.
    • The present invention relates to synthetic green tea derived polyphenolic compounds, their modes of syntheses, and their use in inhibiting proteasomal activity and in treating cancers. The present invention is also directed to pharmaceutical compositions useful in methods of inhibiting proteasomes and of treating ...
    ]]>     20120029067     <![CDATA[DERIVATIVES OF AMINOCYCLOBUTANE OR AMINOCYCLOBUTENE, THEIR METHOD OF PREPARATION AND THEIR USE AS MEDICAL PRODUCTS]]> http://www.patentstorm.us/applications/20120029013/description.html
  • Application Number:  20120029013
  • Publication Date:  2012-02-02
  • Inventors:  Cuisiat, Stéphane; Vacher, Bernard; Newman-Tancredi, Adrian; Vitton, Olivier
    • The present invention concerns compounds of general formula (1), where in:—-a- is a single or double bond, Ar is an aromatic group, substituted or unsubstituted, R1 and R2 each independently or together are: a hydrogen atom or C1-C6 alkyl group, branched or unbranched, saturated or unsaturated, substituted or unsubstituted; the groups R1 and R2 may also form a heterocycle, R3 and R3′ each independently or together are a hydrogen atom or C1-C6 ...
    ]]>     20120029013     <![CDATA[NOVEL COMPOUNDS FOR MEDICAL USE AS PEPTIDASE EFFECTORS]]> http://www.patentstorm.us/applications/20120028995/description.html
  • Application Number:  20120028995
  • Publication Date:  2012-02-02
  • Inventors:  ANSORGE, Siegfried; BANK, Ute; HEIMBURG, Anke; JULIUS, Heiko; NORDHOFF, Karsten; TAEGER, Michael
    • The invention relates to compounds of general formula (I) as set forth in the claims as well as to the use of the compounds of the general formula (1) in the medical field, specifically for use in the suppression of DNA synthesis and inflammatory cytokine production as well as in the stimulation of anti-inflammatory cytokine production in vitro and in vivo. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention ...
    ]]>     20120028995     <![CDATA[ABUSE DETERRENT AND ANTI-DOSE DUMPING PHARMACEUTICAL SALTS USEFUL FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER]]> http://www.patentstorm.us/applications/20120028960/description.html
  • Application Number:  20120028960
  • Publication Date:  2012-02-02
  • Inventors:  King, Clifford Riley; D'Ambrosio, Stephen G.; Bristol, David W.
    • A pharmaceutical composition comprising a drug substance consisting essentially of a pharmaceutically acceptable organic acid addition salt of an amine containing pharmaceutically active compound wherein the amine containing pharmaceutical active compound is selected from the group consisting of racemic or single isomer ritalinic acid or phenethylamine derivatives and the drug substance has a physical form selected from amorphous and ...
    ]]>     20120028960     <![CDATA[Inhibitors Of The Influenza A Virus M2 Proton Channel]]> http://www.patentstorm.us/applications/20120028957/description.html
  • Application Number:  20120028957
  • Publication Date:  2012-02-02
  • Inventors:  Wang, Jun; DeGrado, William F.
    • Provided are compounds that are capable of modulating the activity of the influenza A virus via interaction with the M2 transmembrane protein. Also provided are methods for treating an influenza A-affected disease state or infection comprising administering a composition comprising one or more compounds that have been identified as being capable of interaction with the M2 ...
    ]]>     20120028957     <![CDATA[Compositions and Methods for Labeling and Imaging Phospholipids]]> http://www.patentstorm.us/applications/20120028290/description.html
  • Application Number:  20120028290
  • Publication Date:  2012-02-02
  • Inventor:  Salic, Adrian
    • The present invention provides a method to label phospholipids in vivo based on the metabolic incorporation of an alkynyl- or azido-labeled metabolic precursor into phospholipids. The resulting phospholipids have alkynyl or azido moieties, which, upon reaction with a labeled azide or alkyne, respectively, form labeled compounds that can be visualized using optical or electron microscopy with high sensitivity and spatial resolution in cells or tissue. The present method provides a valuable tool ...
    ]]>     20120028290     <![CDATA[COMPOUNDS, THEIR SYNTHESES, COMPOSITIONS, AND METHODS TO TREAT CANCER]]> http://www.patentstorm.us/applications/20120027844/description.html
  • Application Number:  20120027844
  • Publication Date:  2012-02-02
  • Inventors:  Beckman, Barbara S.; Foroozesh, Maryam; Liu, Jiawang
    • Compounds and their syntheses are disclosed herein. Compositions and pharmaceutical compositions comprising a compound are also described, and include compositions also comprising liposomes. Methods for the treatment of cancer in animals comprising administering a compound or a composition comprising a compound are also ...
    ]]>     20120027844     <![CDATA[NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS]]> http://www.patentstorm.us/applications/20120025183/description.html
  • Application Number:  20120025183
  • Publication Date:  2012-02-02
  • Inventors:  Kamatani, Jun; Yamada, Naoki; Horiuchi, Takayuki; Saitoh, Akihito
    • Provided is an acenaphtho[1,2-k]benzo[e]acephenanthrene derivative represented by general formula (1):

    wherein R1 to R16 are each independently selected from a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted amino group, a substituted or unsubstituted aryl group, and a substituted or unsubstituted heterocyclic ...
    ]]> 20120025183 <![CDATA[ALIPHATIC AMINE BASED NANOCARBONS FOR THE ABSORPTION OF CARBON DIOXIDE]]> http://www.patentstorm.us/applications/20120024153/description.html

  • Application Number:  20120024153
  • Publication Date:  2012-02-02
  • Inventors:  Barron, Andrew R.; Dillon, Eoghan
    • A composition of matter, and method to make same, for a nano-based material including a nanocarbon support to which is attached an aliphatic amine. In particular, the composition of matter is an aliphatic amine-nanocarbon material that includes a nanocarbon (NC) support, such as C60, nano-graphite, graphene, nanocarbon ribbons, graphite intercalation compounds, graphite oxide, nano-coal, nanohorns, and combinations thereof, and further includes an aliphatic amine, such as ...
    ]]>     20120024153     <![CDATA[Axomadol or a Metabolite Thereof for Use in the Treatment of Irritable Bowel Syndrome]]> http://www.patentstorm.us/applications/20120022294/description.html
  • Application Number:  20120022294
  • Publication Date:  2012-01-26
  • Inventors:  Bloms-Funke, Petra; Schroeder, Wolfgang; Schiene, Klaus; Christoph, Thomas
    • The invention relates to axomadol or a metabolite thereof for use in the treatment of irritable bowel ...
    ]]>     20120022294     <![CDATA[ELECTROPHOTOGRAPHIC PHOTORECEPTOR]]> http://www.patentstorm.us/applications/20120022293/description.html
  • Application Number:  20120022293
  • Publication Date:  2012-01-26
  • Inventors:  NAKAMURA, Junji; KOBAYASHI, Tohru
    • An object of the present invention is to provide a charge transport material and an electrophotographic photoreceptor using the charge transport material, the charge transport material sufficiently satisfying characteristics conventionally desired for a charge transport material for an electrophotographic photoreceptor, specifically, the charge transport material having a good solubility in a binder polymer, allowing formation of a stable and high-concentration organic thin film therefrom, and ...
    ]]>     20120022293     <![CDATA[METHOD FOR PREPARING EPLIVANSERIN HEMIFUMARATE]]> http://www.patentstorm.us/applications/20120022292/description.html
  • Application Number:  20120022292
  • Publication Date:  2012-01-26
  • Inventors:  Hoff, Christian; Garcia, Eric
    • Method for preparing eplivanserin ...
    ]]>     20120022292     <![CDATA[PROCESS FOR PRODUCING (S)-3-[(1-DIMETHYLAMINO)ETHYL] PHENYL-N-ETHYL-N-METHYL-CARBAMATE VIA NOVEL INTERMEDIATES]]> http://www.patentstorm.us/applications/20120022281/description.html
  • Application Number:  20120022281
  • Publication Date:  2012-01-26
  • Inventors:  Dubey, Shailendra Kumar; Bansal, Vikas; Pannu, Kamaljeet; Dubey, Sushil Kumar
    • Disclosed herein are novel intermediates and process for large scale production of (S)-3-[(1-dimethylamino)ethyl]phenyl-N-ethyl-N-methyl-carbamate (rivastigmine) or its pharmaceutically acceptable salts employing the novel intermediates. Further provided are methods for producing the novel intermediates ...
    ]]>     20120022281     <![CDATA[METHOD FOR PRODUCING ALDEHYDE FUNCTIONAL COMPOUNDS]]> http://www.patentstorm.us/applications/20120022276/description.html
  • Application Number:  20120022276
  • Publication Date:  2012-01-26
  • Inventors:  Roos, Martin; Meier, Michael A.R.; Rybak, Anastasiya; Geisker, Dominik; Hannen, Peter
    • The invention relates to a method for producing aldehyde functional compounds by a cross-metathesis reaction of an olefinic compound having at least one hydroxy group and at least one C—C double bond with at least one at least monounsaturated fatty acid or at least one at least monounsaturated fatty acid derivative, in the presence of a metathesis catalyst at a maximum temperature of 180° C. and in the presence of at least one reagent that acts as a protective group-forming compound in ...
    ]]>     20120022276     <![CDATA[FLUORINE-CONTAINING N-ALKYLSULFONYLIMIDE COMPOUND, MANUFACTURING METHOD THEREFOR, AND METHOD OF MANUFACTURING AN IONIC COMPOUND]]> http://www.patentstorm.us/applications/20120022269/description.html
  • Application Number:  20120022269
  • Publication Date:  2012-01-26
  • Inventors:  Yatsuyanagi, Hiroyuki; Honda, Tsunetoshi; Konishi, Takashi; Takano, Daisuke
    • According to the method for producing fluorine-containing N-alkylsulfonylimide compound, the fluorine-containing N-alkylsulfonylimide compound can be produced safely with a high recovery rate by alkylating fluorine-containing sulfonylimide acid or fluorine-containing sulfonylimide acid salt with dialkylsulfuric acid or dialkylcarbonic ...
    ]]>     20120022269     <![CDATA[3-AMINOXALYL-AMINOBENZAMIDE DERIVATIVES AND INSECTICIDAL AND MITICIDAL AGENTS CONTAINING SAME AS ACTIVE INGREDIENT]]> http://www.patentstorm.us/applications/20120022263/description.html
  • Application Number:  20120022263
  • Publication Date:  2012-01-26
  • Inventors:  Usui, Shuichi; Fukuchi, Toshiki; Kinoshita, Sachiko
    • The present invention herein provides a 3-aminooxalylaminobenzamide derivative which is used as an insecticide or miticide.

    The 3-aminooxalylaminobenzamide derivative is one represented by the following general formula [1]:

    (R1 and R2 each represent, for instance, a C1 to C3 alkoxy group or a C1 to C3 haloalkoxy group; R3 and ...
    ]]> 20120022263 <![CDATA[PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS]]> http://www.patentstorm.us/applications/20120022252/description.html

  • Application Number:  20120022252
  • Publication Date:  2012-01-26
  • Inventors:  Shekhar, Shashank; Franczyk, Thaddeus S.; Barnes, David M.; Dunn, Travis B.; Haight, Anthony R.; Chan, Vincent S.
    • The disclosure is directed to: (a) phosphacycle ligands; (b) methods of using such phosphacycle ligands in bond forming reactions; and (c) methods of preparing phosphacycle ...
    ]]>     20120022252     <![CDATA[IONIZABLE ISOTOPIC LABELING REAGENTS FOR RELATIVE QUANTIFICATION BY MASS SPECTROMETRY]]> http://www.patentstorm.us/applications/20120022230/description.html
  • Application Number:  20120022230
  • Publication Date:  2012-01-26
  • Inventors:  SMITH, Lloyd M.; SHORTREED, MICHAEL R.; FREY, BRIAN L.; PHILLIPS, MARGARET F.; COON, JOSHUA J.; LAMOS, SHANE M.; KRUSEMARK, CASEY J.; BELSHAW, PETER J.; PATEL, MADHUSUDAN; KELLEHER, NEIL L.
    • Relative quantification of metabolites by Electrospray Ionization Mass Spectrometry (ESI-MS) requiring a mechanism for simultaneous analysis of multiple analytes in two or more samples. Labeling reagents that are reactive to particular compound classes and differ only in their isotopic compositions facilitate relative quantification. Heavy and light isotopic forms of methylacetimidate were synthesized and used as labeling reagents for quantification of amine-containing molecules. Heavy and ...
    ]]>     20120022230     <![CDATA[Salts or Co-Crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol]]> http://www.patentstorm.us/applications/20120022117/description.html
  • Application Number:  20120022117
  • Publication Date:  2012-01-26
  • Inventors:  GRUSS, Michael; KRASZEWSKI, Magda
    • A salt or cocrystal of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol (component a) and at least one acid component (b1) or at least one acid component (b2), wherein the salt or cocrystal of component (a) and component (b2) is present in crystalline and/or amorphous form, a pharmaceutical composition comprising said salt or cocrystal, and a method of treating pain in a subject in need thereof by administering an effective amount of said salt or ...
    ]]>     20120022117     <![CDATA[ANTAGONISTS OF THE TRPV1 RECEPTOR AND USES THEREOF]]> http://www.patentstorm.us/applications/20120022103/description.html
  • Application Number:  20120022103
  • Publication Date:  2012-01-26
  • Inventors:  Bayburt, Erol K.; Lee, Chih-hung; Latshaw, Steven P.; Daanen, Jerome F.; Gomtsyan, Arthur R.; Schmidt, JR., Robert G.
    • The present application is directed to compounds that are TRPV1 antagonists and have formula (I)

    wherein variables Ar1, L1, R1, R2, R3, R4, R5, Y1, Y2, and Y3, are as defined in the description, which are useful for treating disorders caused by or exacerbated by vanilloid receptor ...
    ]]> 20120022103 <![CDATA[CATECHOLAMINE DERIVATIVES FOR OBESITY AND NEUROLOGICAL DISORDERS]]> http://www.patentstorm.us/applications/20120022086/description.html

  • Application Number:  20120022086
  • Publication Date:  2012-01-26
  • Inventor:  Ye, Keqiang
    • Novel compounds, compositions, and methods related to the activation of the TrkB receptor are provided. The methods include administering in vivo or in vitro a therapeutically effective amount of a compound containing a catecholamine backbone and pharmaceutically acceptable salts, prodrugs, and derivatives thereof. Specifically, methods, compositions, and compounds for the treatment of disorders including neurological disorders, neuropsychiatric disorders, and metabolic disorders are provided. ...
    ]]>     20120022086     <![CDATA[Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use]]> http://www.patentstorm.us/applications/20120022070/description.html
  • Application Number:  20120022070
  • Publication Date:  2012-01-26
  • Inventors:  Liotta, Dennis C.; Min, Jaeki; Fu, Haian; Thepchatri, Pahk; Du, Yuhong
    • Novel classes of molecular chaperone Heat shock protein 90 (Hsp90) inhibitors are disclosed. These compounds are useful in treating and preventing cancer and other Hsp90-related diseases and conditions, such as inflammation and neurodegenerative disorders. Methods of treating and preventing cancer and other Hsp90 related diseases and conditions are disclosed that include administering to the subject a therapeutically effective amount of an Hsp90 inhibitor. Methods of preparing the novel Hsp90 ...
    ]]>     20120022070     <![CDATA[NOVEL SUBSTITUTED INDANES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS DRUGS]]> http://www.patentstorm.us/applications/20120022039/description.html
  • Application Number:  20120022039
  • Publication Date:  2012-01-26
  • Inventors:  Wirth, Klaus; Stengelin, Siegfried; Gossel, Matthias; Schwink, Lothar
    • The invention relates to substituted indanes and derivatives thereof, to physiologically acceptable salts and physiologically functional derivatives thereof, to the production thereof, to drugs containing at least one substituted indane according to the invention or derivative thereof, and to the use of the substituted indanes according to the invention and to derivatives thereof as MCH ...
    ]]>     20120022039     <![CDATA[SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES]]> http://www.patentstorm.us/applications/20120022027/description.html
  • Application Number:  20120022027
  • Publication Date:  2012-01-26
  • Inventors:  Dai, Dongcheng; Amberg, Sean M.; Bolken, Tove; Hruby, Dennis E.; Bailey, Thomas R.; Nunberg, Jack H.; Thomas, Celestine Johnson
    • Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel semicarbazides, sulfonyl carbazides, ureas and related compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including ...
    ]]>     20120022027     <![CDATA[AMIDASES AND METHODS OF THEIR USE]]> http://www.patentstorm.us/applications/20120021469/description.html
  • Application Number:  20120021469
  • Publication Date:  2012-01-26
  • Inventors:  Huisman, Gjalt; Jones, Robert J.; Gooding, Owen; Clark, Louis; Yang, Jie
    • The disclosure relates to engineered amidase polypeptides and processes of using the polypeptides for chiral resolution of amino acid amide compounds. The disclosure further relates to the polynucleotides that encode the engineered amidase polypeptides and related vectors, host cells, and methods for making the engineered amidase ...
    ]]>     20120021469     <![CDATA[FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER]]> http://www.patentstorm.us/applications/20120021066/description.html
  • Application Number:  20120021066
  • Publication Date:  2012-01-26
  • Inventors:  Webster, Jeffery D.; Siddall, Thomas L.; Ruiz, James M.; Young, David H.; Shaber, Steven Howard; Avila-Adame, Cruz; Breaux, Nneka T.
    • The present invention relates to the use of hydrazone compounds and copper for controlling the growth of ...
    ]]>     20120021066     <![CDATA[FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER]]> http://www.patentstorm.us/applications/20120021065/description.html
  • Application Number:  20120021065
  • Publication Date:  2012-01-26
  • Inventors:  Webster, Jeffery D.; Siddall, Thomas L.; Ruiz, James M.; Young, David H.; Shaber, Steven Howard; Avila-Adame, Cruz; Breaux, Nneka T.
    • The present invention relates to the use of hydrazone compounds and copper for controlling the growth of ...
    ]]>     20120021065     <![CDATA[Novel Cationic Lipid, A Preparation Method of the Same and A Delivery System Comprising the Same]]> http://www.patentstorm.us/applications/20120021044/description.html
  • Application Number:  20120021044
  • Publication Date:  2012-01-26
  • Inventors:  Oh, Yu-Kyoung; Shin, Hye-Jeong; Suh, Min-Sung; Shim, Ga Yong
    • The present invention provides a novel cationic lipid, a preparation method of the same and a delivery system comprising the same. The cationic lipid of the present invention is used for the preparation of delivery systems of nucleic acids or physiologically active anionic proteins. The cationic lipid of the present invention can be conveniently prepared and purified by a simple process and is therefore economically highly advantageous for industrial-scale production thereof. Further, a nucleic ...
    ]]>     20120021044     <![CDATA[Method for Producing Imide Compound]]> http://www.patentstorm.us/applications/20120020867/description.html
  • Application Number:  20120020867
  • Publication Date:  2012-01-26
  • Inventors:  Nanmyo, Tsutomu; Morinaka, Takayoshi
    • Disclosed is a method for producing “a salt or a complex comprising imide and an organic base”, characterized by reacting halogenated sulfuryl or halogenated phosphoryl with ammonia in the presence of an organic base. According to this method, a target imide compound can be produced in a high yield while significantly suppressing the production of by-products. Further, by reacting the obtained imide compound with an alkali metal hydroxide or an alkaline earth metal hydroxide, an imide metal ...
    ]]>     20120020867